The risk of diabetes vs cardiovascular benefits with statins has been referred to as a "double-edged sword," but "one edge of the sword is sharper than the other," last week's AHA meeting was told after hearing the results of five new studies on this issue.
Heartwire
via Medscape news
Heartwire
via Medscape news
No comments:
Post a Comment